Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Octasa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Octasa 800mg MR gastro-resistant tablets
0105010B0BIAAAS
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 63,053 |
|
Octasa 400mg MR gastro-resistant tablets
0105010B0BIABAA
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 46,083 |
|
Octasa 1600mg MR gastro-resistant tablets
0105010B0BIACBD
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 5,962 |
|
Octasa 1g suppositories
0105010B0BIADAJ
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 1,878 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.